MMedication Read More NVO’s Ozempic Outshines LLY’s Mounjaro in Lowering Cardiovascular RiskOctober 1, 2026 Novo NVO announced new real-world data from the COMPETE SWITCH Cardiovascular (CV) study comparing treatment strategies in adults…